Introducing the Continuous Glucose Data Analysis (CGDA) R Package: An Intuitive Package to Analyze Continuous Glucose Monitoring Data.

IF 3.7 Q2 ENDOCRINOLOGY & METABOLISM Journal of Diabetes Science and Technology Pub Date : 2022-05-01 DOI:10.1177/19322968211070293
Ilias Attaye, Eduard W J van der Vossen, Diogo N Mendes Bastos, Max Nieuwdorp, Evgeni Levin
{"title":"Introducing the Continuous Glucose Data Analysis (CGDA) R Package: An Intuitive Package to Analyze Continuous Glucose Monitoring Data.","authors":"Ilias Attaye, Eduard W J van der Vossen, Diogo N Mendes Bastos, Max Nieuwdorp, Evgeni Levin","doi":"10.1177/19322968211070293","DOIUrl":null,"url":null,"abstract":"The first continuous glucose monitors (CGM) have been introduced more than 20 years ago and today multiple options exist.1 These options consist of real-time CGM (rtCGM) and intermittent CGM (iCGM) or Flash monitors. The rt-CGM measure the glucose levels continuously and can alert if a patient is moving toward a hypoor a hyperglycaemic event. The iCGM, however, only show the glucose levels when the patient actively scans the device. Multiple studies have shown that implementing CGM in routine clinical care has positive effects, regardless of the type of CGM.2 The main benefit is that CGM show real-time glucose levels and fluctuation, thereby overcoming limitations of “old” metrics such as HbA1c and fasting glucose levels. However, despite recommendations, routine use of CGM in clinical practice remains scare.3 A possible explanation for this is the fact that using and interpreting results from CGM remains difficult for health care practitioners. Furthermore, analyses of the data in clinical trials differ widely and are therefore difficult to generalize and use in clinical practice.2 Recently, the American Diabetes Association (ADA) published a guideline on how to use CGM in daily practice.3 To date, no tool exists that can easily and intuitively provide these data from CGM. Several statistical packages do exist that can assist in extracting data from the CGM (e.g., HbA1c, glycemic excursions).4,5 However, a major drawback of these packages is that the user needs to be familiar with programming and the output is often in mg/dL or %, making implementation and interpretation for clinicians that use other metrics difficult. Moreover, analyses packages of manufacturers are not insightful in how analyses are done and which algorithms are used. Through this letter we wish to introduce the Continuous Glucose Data Analysis (CGDA) Package in the programming language R. This is an easy-to-use, free package that incorporates the ADA recommendations, has graphical output, and provides output in all commonly used metrics (i.e., glucose mmol/mol, mg/dL, and HbA1c % as well as mg/dL).","PeriodicalId":15475,"journal":{"name":"Journal of Diabetes Science and Technology","volume":"16 3","pages":"783-785"},"PeriodicalIF":3.7000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294587/pdf/10.1177_19322968211070293.pdf","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/19322968211070293","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 6

Abstract

The first continuous glucose monitors (CGM) have been introduced more than 20 years ago and today multiple options exist.1 These options consist of real-time CGM (rtCGM) and intermittent CGM (iCGM) or Flash monitors. The rt-CGM measure the glucose levels continuously and can alert if a patient is moving toward a hypoor a hyperglycaemic event. The iCGM, however, only show the glucose levels when the patient actively scans the device. Multiple studies have shown that implementing CGM in routine clinical care has positive effects, regardless of the type of CGM.2 The main benefit is that CGM show real-time glucose levels and fluctuation, thereby overcoming limitations of “old” metrics such as HbA1c and fasting glucose levels. However, despite recommendations, routine use of CGM in clinical practice remains scare.3 A possible explanation for this is the fact that using and interpreting results from CGM remains difficult for health care practitioners. Furthermore, analyses of the data in clinical trials differ widely and are therefore difficult to generalize and use in clinical practice.2 Recently, the American Diabetes Association (ADA) published a guideline on how to use CGM in daily practice.3 To date, no tool exists that can easily and intuitively provide these data from CGM. Several statistical packages do exist that can assist in extracting data from the CGM (e.g., HbA1c, glycemic excursions).4,5 However, a major drawback of these packages is that the user needs to be familiar with programming and the output is often in mg/dL or %, making implementation and interpretation for clinicians that use other metrics difficult. Moreover, analyses packages of manufacturers are not insightful in how analyses are done and which algorithms are used. Through this letter we wish to introduce the Continuous Glucose Data Analysis (CGDA) Package in the programming language R. This is an easy-to-use, free package that incorporates the ADA recommendations, has graphical output, and provides output in all commonly used metrics (i.e., glucose mmol/mol, mg/dL, and HbA1c % as well as mg/dL).
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
介绍连续血糖数据分析(CGDA) R包:一个直观的软件包来分析连续血糖监测数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Diabetes Science and Technology
Journal of Diabetes Science and Technology Medicine-Internal Medicine
CiteScore
7.50
自引率
12.00%
发文量
148
期刊介绍: The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology including glucose monitoring, insulin and metabolic peptide delivery, the artificial pancreas, digital health, precision medicine, social media, cybersecurity, software for modeling, physiologic monitoring, technology for managing obesity, and diagnostic tests of glycation. The journal also covers the development and use of mobile applications and wireless communication, as well as bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors. Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes.
期刊最新文献
Glucodensity-Based Models Outperform Time in Range and Glycemia Risk Index in Prediction Models. Do Insulin Pumps Dispense Unwanted or Incorrect Insulin Doses During a Flight? Marked Increases in Continuous Glucose Monitor-Detected Hypoglycemia During a Seven-Day Water-Only Fast in Healthy Men and Women. Continuous Glucose Monitoring in Diabetes Care in Saudi Arabia: Addressing Performance Standards and Regulatory Gaps-Literature Review and Consensus Report. Performance of an Automated Insulin Delivery System in Youth With Type 1 Diabetes During a Diabetes Summer Camp.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1